Prostate Cancer Treatment

Darolutamide (NUBEQA) 300MG Tablet

$34,405.00

Darolutamide Nubeqa 300mg Tablet is a medication used in the treatment of prostate cancer, specifically non-metastatic castration-resistant prostate cancer (nmCRPC). It contains darolutamide as its active ingredient, which belongs to a class of drugs known as androgen receptor inhibitors.

Quantity

Darolutamide (NUBEQA) 300MG Tablet quantity

Add to cart

Tag:

Darolutamide NUBEQA

Description

Darolutamide Nubeqa 300mg Tablet is a medication used in the treatment of prostate cancer, specifically non-metastatic castration-resistant prostate cancer (nmCRPC). It contains darolutamide as its active ingredient, which belongs to a class of drugs known as androgen receptor inhibitors. Darolutamide works by blocking the effects of androgens (male hormones) on prostate cancer cells, thereby slowing down the progression of the disease.

Key Features:

• Androgen Receptor Inhibitor: Darolutamide is an androgen receptor inhibitor that works by blocking the androgen receptors on prostate cancer cells, preventing them from receiving signals that promote their growth and proliferation.
• Treatment of Prostate Cancer: Darolutamide Nubeqa 300mg Tablet is indicated for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC), a form of prostate cancer that continues to grow and spread despite low levels of testosterone in the body. It is used in combination with androgen deprivation therapy (ADT) to slow down the progression of the disease.
• Oral Administration: Darolutamide Nubeqa 300mg Tablet is administered orally, typically twice daily, with or without food. The convenient dosing regimen enhances patient compliance and adherence to treatment.
• Efficacy: Clinical trials have demonstrated the efficacy of darolutamide in delaying the progression of prostate cancer and prolonging metastasis-free survival in patients with nmCRPC. It has shown superiority over placebo in slowing down the spread of the disease and improving overall survival rates.
• Side Effects: Common side effects associated with darolutamide may include fatigue, back pain, nausea, diarrhea, and decreased appetite. Patients should be closely monitored for signs of adverse reactions, and healthcare providers should be informed